Therapeutic Potential of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Curr Stem Cell Res Ther. 2019;14(6):460-465. doi: 10.2174/1574888X14666190214162453.

Abstract

Endothelial progenitor cells (EPCs) are implicated in multiple biologic processes such as vascular homeostasis, neovascularization and tissue regeneration, and tumor angiogenesis. A subtype of EPCs is referred to as endothelial colony-forming cells (ECFCs), which display robust clonal proliferative potential and can form durable and functional blood vessels in animal models. In this review, we provide a brief overview of EPCs' characteristics, classification and origins, a summary of the progress in preclinical studies with regard to the therapeutic potential of human umbilical cord blood derived ECFCs (CB-ECFCs) for ischemia repair, tissue engineering and tumor, and highlight the necessity to select high proliferative CB-ECFCs and to optimize their recovery and expansion conditions.

Keywords: Endothelial colony forming cells (ECFCs); neovascularization; peripheral blood; tissue engineering; tumor angiogenesis; vascular homeostasis..

Publication types

  • Review

MeSH terms

  • Animals
  • Cell- and Tissue-Based Therapy / methods*
  • Endothelial Progenitor Cells*
  • Fetal Blood / cytology*
  • Humans
  • Ischemia / therapy
  • Tissue Engineering / methods